Long COVID and cardiac function

Recent research has confirmed the lethal ‘acute’ effects of the COVID-19 virus on the heart, but there is a growing concern and increasing number of those individuals infected by the virus to remain ‘chronic’ as long-haulers, i.e., Long COVID. There are estimates that as many as 40-60% of individuals infected continue to experience symptoms for up to 12 weeks, and as many as 10-20% continue to experience symptoms longer than 12 weeks. Thus, the proposed research will investigate the effects on Long COVID on the heart using the LLA Recordis™ cardiac sensor and echocardiography. We have demonstrated previously that the LLA Recordis™ cardiac sensor can measure and record how the heart is contracting and relaxing with every heartbeat. The current research will help us to understand the long-term complications on the heart. This research will assist LLA Technologies Inc. to enter the global market to commercialize their cardiac sensor and become a leader in Canada and globally for cardiac diagnostics.

Faculty Supervisor:

Patrick Neary;Lanishan Bhagaloo

Student:

Partner:

LLA Technologies Inc

Discipline:

Life Sciences

Sector:

Manufacturing

University:

University of Regina

Program: